Atlas Trials

Cannabis Extract in Refractory Epilepsy Study

Clinical trial NCT03808935 · TERMINATED

Trial details

NCT number
NCT03808935
Sponsor
The Epilepsy Research Program of the Ontario Brain Institute
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Drug Resistant Epilepsy
Start date
2019-01-10
Primary completion
2020-03-15
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.